stockrowIntegra LifeSciences Holdings Corporation (IART) vs SiBone (SIBN)
- Integra LifeSciences Holdings Corporation IART 13.70 −2.97%
- SiBone SIBN 24.37 +0.41%
Integra LifeSciences Holdings Corporation and SiBone are both Medical Devices companies. Integra LifeSciences Holdings Corporation and SiBone are of similar size ($1.1B and $1.1B). SiBone has negative trailing earnings, so its P/E is not meaningful; Integra LifeSciences Holdings Corporation trades at 83.0×. SiBone grew revenue faster over the last twelve months: 14.0% against 0.84%. Integra LifeSciences Holdings Corporation has the higher net margin (0.79% vs −6.20%) and the higher return on invested capital (1.79% vs −14.1%). Across the 18 metrics below, Integra LifeSciences Holdings Corporation leads on 12 and SiBone on 6.
Valuation
Profitability
| Metric | IART | SIBN | Medical Devices median |
|---|---|---|---|
| Gross margin | 52.36% | 79.40% | 57.76% |
| Operating margin | 4.39% | (7.57%) | (15.07%) |
| Net margin | 0.79% | (6.20%) | (14.45%) |
| Free cash flow margin | 5.18% | (1.90%) | (3.88%) |
| Return on equity | 1.24% | (7.67%) | (10.35%) |
| Return on assets | 0.36% | (5.57%) | (17.26%) |
| Return on invested capital | 1.79% | (14.10%) | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack